Skip to main content
SpringerLink
Log in

Conversion from Intravenous to Oral Ciprofloxacin: Observing the “Like-to-Like” Phenomenon

  • Conference paper
Ciprofloxacin i.v.

  • 68 Accesses

Abstract

In hospitalized patients serious infectious diseases are traditionally treated using intravenous antimicrobial agents with conversion to oral drugs, often occurring late in the course of therapy. Because of cost-containment pressures the concept of switching to oral agents early in the course of antibiotic therapy is important, and this has become a major goal of antibiotic monitoring programs [1–10]. In several of these programs [1, 6, 8] particular attention has been placed on oral fluoroquinolones, for these agents exhibit favorable pharmacokinetic and microbiologic characteristics, have shown efficacy in the treatment of a variety of infectious diseases [1, 11], and can reduce the cost of antibiotic therapy [12–17].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Belliveau P, Nightingale CH, Quintiliani R, Crowe H, Gousee G (1993) Oral ciprofloxacin, ofloxacin, and lomefloxacin as alternatives to intravenous antimicrobial therapy. Conn Med 57:539–545

    PubMed  CAS  Google Scholar 

  2. Briceland LL, Lesar TS, Lomaestro BM, Lombardi TP, Gailey RA, Kowalsky SF (1989) Streamling antimicrobial therapy through pharmacists’ review of order sheets. Am J Hosp Pharm 46:1376–1380

    PubMed  CAS  Google Scholar 

  3. Briceland LL, Nightingale CH, Quintiliani R, Cooper BW, Smith KS (1988) Pharmacoeconomics: antibiotic streamlining utilizing an interdisciplinary approach. Arch Intern Med 148:2019–2022

    Article  PubMed  CAS  Google Scholar 

  4. Burnakis TG (1992) A cost effective approach to treatment of infection: “switch therapy”. Hosp Pharm 27:353–360

    PubMed  CAS  Google Scholar 

  5. Capers CC, Bess DT, Branam AC, et al. (1993) Antibiotic surveillance: the results of a clinical pharmacy interventions program. Hosp Pharm 28:206–212

    PubMed  CAS  Google Scholar 

  6. Frighetto L, Nickoloff D, Martinusen SM, Mamdani FS, Jewesson PJ (1992) Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital. Ann Pharmacother 26:1447–1451

    PubMed  CAS  Google Scholar 

  7. Kortas K, Segreti J, Donnelly A, Pierpaoli P, Trenholme G, Levin S (1993) An anti-infective review and monitoring program. Pharm Ther 18:291–296

    Google Scholar 

  8. Nightingale CH, Lubowski TJ, On A, Quintiliani R (1992) Formulary status of quinolone antibiotics: one institution’s approach. Hosp Formul 27:509–516

    PubMed  CAS  Google Scholar 

  9. Pastel DA, Chang S, Nessim S, Shane R, Morgan MA (1992) Department of pharmacy-initiated program for streamlining empirical antibiotic therapy. Hosp Pharm 27:596–614

    PubMed  CAS  Google Scholar 

  10. Quintiliani R, Cooper BW, Briceland LL, Nightingale CH (1987) Economic impact of streamlining antibiotic administration. Am J Med 82 [Suppl 4A]: 391–394

    PubMed  CAS  Google Scholar 

  11. Hooper DC, Wolfson JS (1991) Fluoroquinolone antimicrobial agents. N Engl Med 324:384–394

    Article  CAS  Google Scholar 

  12. Paladino JA, Sperry HE, Backes JM, et al. (1991) Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med 91:462–670

    Article  PubMed  CAS  Google Scholar 

  13. Fliegelman RM, Mattingly PM, Dempsey CL, Sokalski SJ (1990) Economic impact of oral ciprofloxacin following standard intravenous therapy. Diagn Microbiol Infect Dis 13:187–189

    Article  PubMed  CAS  Google Scholar 

  14. Grasela TH, Paladino JA, Schentag JJ, et al. (1991) Clinical and economic impact of oral ciprofloxacin as follow-up to parenteral antibiotics. Ann Pharmacotherapy 25:857–862

    Google Scholar 

  15. Powers T, Bingham DH (1990) Clinical and economic effect of ciprofloxacin as an alternative to injectable antimicrobial therapy. Am J Hosp Pharm 47:1781–1784

    PubMed  CAS  Google Scholar 

  16. Marchbanks CR, Graham KK, Barnes J, Dudley MN (1991) Pharmacoepidemiology of ciprofloxacin: analysis of use patterns and cost impact. Pharmacotherapy 11:50–55

    PubMed  CAS  Google Scholar 

  17. Balfour JA, Faulds D (1993) Oral ciprofloxacin. A pharmacoeconomic evaluation of its use in the treatment of serious infections. Pharmacoeconomics 3:398–421

    Article  PubMed  CAS  Google Scholar 

  18. Haddow A, Greene S, Heinz G, Wantuck D (1989) Ciprofloxacin (intravenous/oral) versus ceftazidime in lower respiratory tract infections. Am J Med [Suppl 5A]:113S-115S

    Google Scholar 

  19. Yoshioka K, Youngs DJ, Keighley MRB (1991) A randomized prospective controlled study of ciprofloxacin with metronidazole in the treatment of intra-abdo-minal infection. Infection 19:29–33

    Article  Google Scholar 

  20. White CW, Albanese MA, Brown DD, Caplan RM (1985) The effectiveness of continuing medical education in changing the behavior of physicians caring for patients with acute myocardial infarction: a controlled randomized trial. Ann Intern Med 102:686–692

    PubMed  CAS  Google Scholar 

  21. Kosecoff J, Kanouse DE, Rogers WH, McCloskey L, Winslow CM, Brook RH (1987) Effects of National Institutes of Health Consensus Development Program on Physician Practice. JAMA 258:2708–2713

    Article  PubMed  CAS  Google Scholar 

  22. Spiegel JS, Shapiro MF, Berman B, Greenfield S (1989) Changing physician test ordering in a university hospital: an intervention of physician participation, explicit criteria, and feedback. Arch Intern Med 149:549–553

    Article  PubMed  CAS  Google Scholar 

  23. Wachtel TJ, O’Sullivan P (1990) Practice guidelines to reduce testing in the hospital. J Gen Intern Med 5:335–341

    Article  PubMed  CAS  Google Scholar 

  24. Avorn J, Soumerai SB, Taylor W, Wessels MR, Janousek J, Weiner M (1988) Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med 148:1720–1724

    Article  PubMed  CAS  Google Scholar 

  25. Zaat JO, Van Eijk JT, Bonte HA (1992) Laboratory test form design influences test ordering by general practitioners in the Netherlands. Med Care 30:189–198

    Article  PubMed  CAS  Google Scholar 

  26. Greco PJ, Eisenberg JM (1993) Changing physicians’ practices. N Engl J Med 329:1271–1274

    Article  PubMed  CAS  Google Scholar 

  27. Quintiliani R, Cooper BW, Briceland LL, Nightingale CH (1987) Formulary replacement policies: cefotetan vs cefoxitin. Infect Med 4:275–279

    Google Scholar 

  28. Briceland L, Quintiliani R, Nightingale CH (1988) Multidisciplinary cost-containment program promoting oral metronidazole for treatment of antibiotic-associated colitis. Am J Hosp Pharm 32:122–125

    Google Scholar 

  29. Briceland LL, Nightingale CH, Quintiliani R, Cooper B (1988) Multidisciplinary cost-containment program promoting less frequent administration of injectable mezlocillin. Am J Hosp Pharm 45:1082–1085

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. C. H. Nightingale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. P. Belliveau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Quintiliani
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. John Radcliffe Hospital, Oxford, OX3 9 DU, UK

    Christopher Garrard (Intensive Care Director) (Intensive Care Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Nightingale, C.H., Belliveau, P.P., Quintiliani, R. (1994). Conversion from Intravenous to Oral Ciprofloxacin: Observing the “Like-to-Like” Phenomenon. In: Garrard, C. (eds) Ciprofloxacin i.v.. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79098-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79098-0_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-79100-0

  • Online ISBN: 978-3-642-79098-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation